The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
Renal Effects of COX-2-Selective Inhibitors
Abstract
Although nonsteroidal anti-inflammatory drugs (NSAIDs) effectively treat a variety of inflammatory diseases, these agents may cause deleterious effects on kidney function, especially with respect to solute homeostasis and maintenance of renal perfusion and glomerular filtration. NSAIDs act by reducing prostaglandin biosynthesis through inhibition of cyclooxygenase (COX) which exists as two isoforms (COX-1 and COX-2). NSAID-induced gastrointestinal toxicity is generally believed to occur through blockade of COX-1 activity, whereas the anti-inflammatory effects of NSAIDs are thought to occur primarily through inhibition of the inducible isoform, COX-2. However, the situation in the kidney may be somewhat different. Recent studies have demonstrated that COX-2 is constitutively expressed in renal tissues of all species; this isoform may, therefore, be intimately involved in prostaglandin-dependent renal homeostatic processes. Drugs that selectively inhibit COX-2 might, therefore, be expected to produce effects on renal function similar to nonselective NSAIDs which inhibit both COX-1 and COX-2. This assertion is borne out by recent clinical studies showing that the COX-2 inhibitors rofecoxib and celecoxib procedure qualitative changes in urinary prostaglandin excretion, glomerular filtration rate, sodium retention, and their consequences similar to nonselective NSAIDs. It, therefore, seems unlikely that these COX-2 inhibitors (and perhaps their successors) will offer renal safety benefits over nonselective NSAID therapies, and, at this juncture, it is reasonable to assume that all NSAIDs, including COX-2-selective inhibitors, share a similar risk for adverse renal effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
Silverstein, F. E., Faich, G., Goldstein, J. L., Simon, L. S., Pincus, T., Whelton, A., Makuch, R., Eisen, G., Agrawal, N. M., Stenson, W. F., et al. (2000) · JAMA · doi:10.1001/jama.284.10.1247 · Cited by 3,154
Kujubu, D. A., Fletcher, B. S., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98774-0 · Cited by 1,789
Xie, W. L., Chipman, J. G., Robertson, D. L., Erikson, R. L., & Simmons, D. L. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.7.2692 · Cited by 1,707
McAdam, B. F., Catella-Lawson, F., Mardini, I. A., Kapoor, S., Lawson, J. A., & FitzGerald, G. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.1.272 · Cited by 1,305
Meade, E. A., Smith, W. L., & DeWitt, D. L. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)53294-4 · Cited by 1,256
Herschman, H. R. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(95)00194-8 · Cited by 1,197
Langenbach, R., Morham, S. G., Tiano, H. F., Loftin, C. D., Ghanayem, B. I., Chulada, P. C., Mahler, J. F., Lee, C. A., Goulding, E. H., Kluckman, K. D., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90126-4 · Cited by 1,123
Renal Syndromes Associated with Nonsteroidal Antiinflammatory Drugs
Clive, D. M., & Stoff, J. S. (1984) · New England Journal of Medicine · doi:10.1056/nejm198403013100905 · Cited by 1,122
Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse
Morham, S. G., Langenbach, R., Loftin, C. D., Tiano, H. F., Vouloumanos, N., Jennette, J. C., Mahler, J. F., Kluckman, K. D., Ledford, A., Lee, C. A., et al. (1995) · Cell · doi:10.1016/0092-8674(95)90125-6 · Cited by 1,082
Renal abnormalities and an altered inflammatory response in mice lacking cyclooxygenase II
Dinchuk, J. E., Car, B. D., Focht, R. J., Johnston, J. J., Jaffee, B. D., Covington, M. B., Contel, N. R., Eng, V. M., Collins, R. J., Czerniak, P. M., et al. (1995) · Nature · doi:10.1038/378406a0 · Cited by 969
Harris, R. C., McKanna, J. A., Akai, Y., Jacobson, H. R., Dubois, R. N., & Breyer, M. D. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117620 · Cited by 860
cDNA cloning and functional activity of a glucocorticoid-regulated inflammatory cyclooxygenase.
O'Banion, M. K., Winn, V. D., & Young, D. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.11.4888 · Cited by 821
Paracrine regulation of the renal microcirculation
Navar, L. G., Inscho, E. W., Majid, S. A., Imig, J. D., Harrison-Bernard, L. M., & Mitchell, K. D. (1996) · Physiological Reviews · doi:10.1152/physrev.1996.76.2.425 · Cited by 741
Do Nonsteroidal Anti-inflammatory Drugs Affect Blood Pressure? A Meta-Analysis
Johnson, A. G., Nguyen, T. V., & Day, R. O. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-121-4-199408150-00011 · Cited by 717
Whelton, A. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00113-8 · Cited by 704
Adverse Upper Gastrointestinal Effects of Rofecoxib Compared With NSAIDs
Langman, M. J. (1999) · JAMA · doi:10.1001/jama.282.20.1929 · Cited by 686
Catella-Lawson, F., McAdam, B., Morrison, B. W., Kapoor, S., Kujubu, D., Antes, L., Lasseter, K. C., Quan, H., Gertz, B. J., & Fitzgerald, G. A. (1999) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)38195-9 · Cited by 597
Self-citationA serum- and glucocorticoid-regulated 4-kilobase mRNA encodes a cyclooxygenase-related protein.
O'Banion, M. K., Sadowski, H. B., Winn, V., & Young, D. A. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)54491-4 · Cited by 557
A Meta-analysis of the Effects of Nonsteroidal Anti-inflammatory Drugs on Blood Pressure
Pope, J. E. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.1993.00410040045007 · Cited by 527
Page, J., & Henry, D. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.6.777 · Cited by 517
Urinary prostaglandins. Identification and origin.
Frölich, J. C., Wilson, T. W., Sweetman, B. J., Smigel, M., Nies, A. S., Carr, K., Watson, J. T., & Oates, J. A. (1975) · Journal of Clinical Investigation · doi:10.1172/jci107987 · Cited by 479
Clinical Implications of Prostaglandin and Thromboxane A2Formation
Oates, J. A., FitzGerald, G. A., Branch, R. A., Jackson, E. K., Knapp, H. R., & Roberts, L. J. (1988) · New England Journal of Medicine · doi:10.1056/nejm198809223191206 · Cited by 444
Komhoff, M., Grone, H. J., Klein, T., Seyberth, H. W., & Nusing, R. M. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.272.4.f460 · Cited by 365
van Hecken, A., Schwartz, J. I., Depré, M., de Lepeleire, I., Dallob, A., Tanaka, W., Wynants, K., Buntinx, A., Arnout, J., Wong, P. H., et al. (2000) · The Journal of Clinical Pharmacology · doi:10.1177/009127000004001005 · Cited by 354
Self-citationStokes, J. B., & Kokko, J. P. (1977) · Journal of Clinical Investigation · doi:10.1172/jci108733 · Cited by 341
Renal effects of selective cyclooxygenase-2 inhibition in normotensive salt-depleted subjects
ROSSAT, J., MAILLARD, M., NUSSBERGER, J., BRUNNER, H., & BURNIER, M. (1999) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(99)70056-1 · Cited by 318
The clinical significance of inhibition of renal prostaglandin synthesis
Patrono, C., & Dunn, M. J. (1987) · Kidney International · doi:10.1038/ki.1987.164 · Cited by 296
Regulation of cyclooxygenase expression in the kidney by dietary salt intake
Yang, T., Singh, I., Pham, H., Sun, D., Smart, A., Schnermann, J. B., & Briggs, J. P. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.274.3.f481 · Cited by 288
Effects of Celecoxib and Naproxen on Renal Function in the Elderly
Whelton, A., Schulman, G., Wallemark, C., Drower, E. J., Isakson, P. C., Verburg, K. M., & Geis, G. S. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.10.1465 · Cited by 280
Brater, D. C. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00369-1 · Cited by 247
Self-citationEffects of nonsteroidal anti-inflammatory drugs on prostaglandins and renal function
Carmichael, J., & Shankel, S. W. (1985) · The American Journal of Medicine · doi:10.1016/0002-9343(85)90223-2 · Cited by 235
Initiation of Antihypertensive Treatment During Nonsteroidal Anti-inflammatory Drug Therapy
Gurwitz, J. H. (1994) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1994.03520100043031 · Cited by 220
GARELLA, S., & MATARESE, R. A. (1984) · Medicine · doi:10.1097/00005792-198405000-00003 · Cited by 219
Indomethacin-Induced Prostaglandin Inhibition with Hyperkalemia
Tan, S. Y., SHAPIRO, R., FRANCO, R., STOCKARD, H., & Mulrow, P. J. (1979) · Annals of Internal Medicine · doi:10.7326/0003-4819-90-5-783 · Cited by 189
Are selective COX-2 inhibitors nephrotoxic?
Perazella, M. A., & Eras, J. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70266-6 · Cited by 171
Renal Safety and Tolerability of Celecoxib, a Novel Cyclooxygenase-2 Inhibitor
Whelton, A., Maurath, C. J., Verburg, K. M., & Geis, G. S. (2000) · American Journal of Therapeutics · doi:10.1097/00045391-200007030-00004 · Cited by 167
Cloning, expression, and regulation of rabbit cyclooxygenase-2 in renal medullary interstitial cells
Guan, Y., Chang, M., Cho, W., Zhang, Y.-C., Redha, R., Davis, L., Chang, S., DuBois, R. N., Hao, C., & Breyer, M. D. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.1.f18 · Cited by 148
Renal Identification of Cyclooxygenase-2 in a Subset of Thick Ascending Limb Cells
Vio, C. P., Céspedes, C., Gallardo, P. A., & Masferrer, J. L. (1997) · Hypertension · doi:10.1161/01.hyp.30.3.687 · Cited by 138
Nonsteroidal anti-inflammatory drugs and antihypertensives
Houston, M. C. (1991) · The American Journal of Medicine · doi:10.1016/0002-9343(91)90485-g · Cited by 137
NSAIDs and Increased Blood Pressure: What is the Clinical Significance?
Johnson, A. G. (1997) · Drug Safety · doi:10.2165/00002018-199717050-00001 · Cited by 135
Cyclooxygenase-2 in rat nephron development
Zhang, M., Wang, J., Cheng, H., Harris, R. C., & McKanna, J. A. (1997) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1997.273.6.f994 · Cited by 135
Immunolocalization of cyclooxygenase‐2 in the macula densa of human elderly
Nantel, F., Meadows, E., Denis, D., Connolly, B., Metters, K. M., & Giaid, A. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)01088-1 · Cited by 121
Coordinate Expression of Cyclooxygenase-2 and Renin in the Rat Kidney in Renovascular Hypertension
Hartner, A., Goppelt‐Struebe, M., & Hilgers, K. F. (1998) · Hypertension · doi:10.1161/01.hyp.31.1.201 · Cited by 113
Selective increase of cyclooxygenase-2 expression in a model of renal ablation
Wang, J., Cheng, H., Zhang, M., McKanna, J. A., & Harris, R. C. (1998) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1998.275.4.f613 · Cited by 113
Effects of ibuprofen, naproxen, and sulindac on prostaglandins in men
Brater, D. C., Anderson, S. A., Baird, B., & Campbell, W. B. (1985) · Kidney International · doi:10.1038/ki.1985.11 · Cited by 109
Self-citationMeasurement of renal and non-renal eicosanoid synthesis
Catella, F., Nowak, J., & FitzGerald, G. A. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90905-8 · Cited by 108
Regulation of renal function by prostaglandin E receptors
Breyer, M. D., Zhang, Y.-H., Guan, Y., Hao, C., Hébert, R., & BREYER, R. M. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.06718.x · Cited by 97
Upregulation of renal and systemic cyclooxygenase-2 in patients with active lupus nephritis.
Tomasoni, S., Noris, M., Zappella, S., Gotti, E., Casiraghi, F., Bonazzola, S., Benigni, A., & Remuzzi, G. (1998) · Journal of the American Society of Nephrology · doi:10.1681/asn.v971202 · Cited by 95
Renal complications associated with use of nonsteroidal anti-inflammatory agents.
Palmer, B. F. (1995) · PubMed · Cited by 89
Antihypertensive efficacy of angiotensin converting enzyme inhibition and aspirin counteraction
Guazzi, M. D., Campodonico, J., Celeste, F., Guazzi, M., Santambrogio, G. M., Rossi, M., Trabattoni, D., & Alimento, M. (1998) · Clinical Pharmacology & Therapeutics · doi:10.1016/s0009-9236(98)90123-0 · Cited by 65
Effect of indomethacin on salt and water homeostasis
Brater, D. C. (1979) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1979253322 · Cited by 59
Self-citationPorile, J. L., Bakris, G. L., & Garella, S. (1990) · The Journal of Clinical Pharmacology · doi:10.1002/j.1552-4604.1990.tb03487.x · Cited by 57
Tumor Promoter-Inducible Genes Are Differentially Expressed in the Developing Mouse
Tippetts, M. T., Varnum, B. C., Lim, R. W., & Herschman, H. R. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4570-4572.1988 · Cited by 55
Incidence of hyperkalaemia induced by indomethacin in a hospital population.
Zimran, A., Kramer, M. R., Plaskin, M., & Hershko, C. (1985) · BMJ · doi:10.1136/bmj.291.6488.107 · Cited by 49
Edema Associated With Ibuprofen Therapy
Schooley, R. T. (1977) · JAMA · doi:10.1001/jama.1977.03270430058021 · Cited by 43
Are COX-2 selective inhibitors nephrotoxic?
Mj, D. (2000) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(00)70274-5 · Cited by 33
Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Blood Pressure
Fierro-Carrion, G. A., & Ram, C. V. S. (1997) · The American Journal of Cardiology · doi:10.1016/s0002-9149(97)00514-6 · Cited by 27
Cited by
2013 ACCF/AHA Guideline for the Management of Heart Failure
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.05.019 · Cited by 12,536
ACC/AHA 2005 Guideline Update for the Diagnosis and Management of Chronic Heart Failure in the Adult
Hunt, S. A. (2005) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2005.08.022 · Cited by 4,154
2005 WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2009) · Circulation · doi:10.1161/circulationaha.109.192065 · Cited by 3,720
WRITING COMMITTEE MEMBERS, Hunt, S. A., Abraham, W. T., Chin, M. H., Feldman, A. M., Francis, G. S., Ganiats, T. G., Jessup, M., Konstam, M. A., Mancini, D. M., et al. (2005) · Circulation · doi:10.1161/circulationaha.105.167586 · Cited by 2,251
Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T., Januzzi, J. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e31829e8776 · Cited by 2,106
Metadata
- Authors
- Brater, D. C., Harris, C., Redfern, J. S., & Gertz, B. J.
- Venue
- American Journal of Nephrology
- Publisher
- S. Karger AG
- Published
- 2001
- Volume
- 21
- Issue
- 1
- Pages
- 1-15
- ISSN
- 0250-8095 (ISSN-L)
- 1421-9670
- OpenAlex
- W2062159035
- Cited by
- 265
- References
- 58
- FWCI
- 17.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.